PANBELA THERAPEUTICS
Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Panbela Therapeutics has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, Arizona, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre in Adelaide, Australia. Founded in 2011, the company is based in Minnesota, United States.
PANBELA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Minnesota City, Minnesota, United States
Country:
United States
Website Url:
http://www.sunbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(952)479-1196
Email Addresses:
[email protected]
Total Funding:
22.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud Gravatar Profiles OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-22 | Cancer Prevention Pharmaceuticals | Cancer Prevention Pharmaceuticals acquired by Panbela Therapeutics | N/A |
| 2015-09-07 | Cimarron Medical | Cimarron Medical acquired by Panbela Therapeutics | N/A |
Investors List
Florida Institute for the Commercialization of Florida Technology
Florida Institute for the Commercialization of Florida Technology investment in Venture Round - Panbela Therapeutics
Official Site Inspections
http://www.sunbiopharma.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Panbela Therapeutics"
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment …See details»
Panbela Therapeutics - Crunchbase Company Profile
Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The …See details»
Sun BioPharma | VentureRadar
Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and MGI Pharma, a biopharmaceutical company focused on …See details»
www.sunbiopharma.com
Www.sunbiopharma.comSee details»
David Kaysen Named President & CEO of Sun BioPharma
Sep 16, 2015 Kaysen brings to Sun BioPharma more than 25 years of healthcare clinical development, commercial and public company achievements. He joins the Company as its …See details»
Sun BioPharma renames to Panbela Therapeutics
Dec 2, 2020 The name change takes effect Dec. 2. Discover more about S&P Global’s offeringsSee details»
Sun BioPharma Company Overview, Contact Details
Sun BioPharma, Inc. hired Jennifer K. Simpson as President and Chief Executive Officer on Jul 16th '20. · Company founder Michael T. Cullen, M.D. will continue to serve as Executive …See details»
Sun Biopharma Inc. | Key People and Executives - statinvestor.com
Sun BioPharma Inc. is a clinical-stage biopharmaceutical company, which engages in the development of disruptive therapeutics for medical purposes. It focuses on development …See details»
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics
Dec 1, 2020 Contact Information: Investors: James Carbonara Hayden IR (646) 755-7412 [email protected] Media: Tammy Groene Panbela Therapeutics, Inc. (952) 479-1196 …See details»
2019 Annual Report
SUN BIOPHARMA, INC. 712 Vista Boulevard #305 Waconia, Minnesota 55387 PROXY STATEMENT The Board of Directors of Sun BioPharma, Inc. (“our Company”) is soliciting …See details»
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
Dec 1, 2020 --Sun BioPharma, Inc., a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of …See details»
Sun BioPharma, Inc. Announces Leadership Changes
Organization. Effective October 31, 2018, David B. Kaysen is stepping down as President, CEO and Board member of Sun BioPharma, Inc. and its wholly owned subsidiary, Sun BioPharma …See details»
Sun Biopharma - Overview, News & Similar companies - ZoomInfo
Mar 24, 2022 Sun BioPharma Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. T he company's initial …See details»
Sun BioPharma, Inc. Announces Leadership Changes
Oct 31, 2018 Contact Data Contact Information: Investor & Media Contact: Susan Horvath – Sun BioPharma, Inc. 952 479 1196See details»
Sun BioPharma names Jennifer Simpson as president and CEO
Jul 17, 2020 Sun BioPharma (OTCQB:SNBP) appointed Jennifer Simpson as president and CEO, replacing co-founder Michael Cullen, who will continue to serve as the company’s …See details»
Sun BioPharma, Inc. Company Profile & Introduction - Tiger Brokers
Sun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the …See details»
Sun BioPharma, Inc. Provides Business Update and Reports Q3
Nov 12, 2020 Sun BioPharma Inc. is dedicated to treating patients with pancreatic cancer and exploring SBP-101’s potential for efficacy in combination with other agents and in treating …See details»
Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP …
Jul 1, 2020 UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, …See details»
Sun BioPharma, Inc. Announces Appointment of Susan Horvath as …
As an organization. It is with gratitude and respect that we send our best wishes with Scott as he moves on to a new opportunity.” About SBP-101 SBP-101 is a first-in-class, proprietary …See details»
Three-medical linkage in China: trend evolution and obstacle ...
Apr 2, 2025 This study adhered to the general standards for healthcare service ratings set by the World Health Organization and World Bank, as well as the specific requirements outlined in …See details»